PROVIDER PROFILE · NPI 1528024098

Philip RaskinMD

PRACTICEUT SOUTHWESTERNSee all providers at this practice →

EndocrinologyDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

137

Unique beneficiaries

—

Total services

262

Distinct HCPCS

Medicare payment

$22K

Peer benchmark

Total Medicare services vs. 484 Endocrinology providers in TX — bottom quintile (cohort median 868).

PRESCRIBING · PART D · 2024

Total Rx claims

1,039

Beneficiaries

—

Total drug cost

$413K

Distinct drugs

Brand share

60.3%

Top prescribed drugs

Insulin Glargine,hum.Rec.Anlog88 claims

Semaglutide76 claims

Metformin Hcl65 claims

Levothyroxine Sodium64 claims

Simvastatin46 claims

QUALITY · MIPS · 2024

Final MIPS score

82.9

Quality

70.2

Cost

72.8

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.33%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Philip Raskin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS	37	148
Eric Steen Internal Medicine · Dallas, TX	20	46
WICK, SARA	13	45
MALMBERG, CARL	11	25
Christopher Lu Nephrology · Dallas, TX	11	45

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history